



HD - CAGRILINTIDE - 5MG - VIAL
R1,100.00
Cagrilintide Use:
Cagrilintide and Obesity:
Researchers have carried out two important studies of Cagrilintide to better understand the effects of peptide on weight loss. In one study, participants received weekly doses of Cagrilintide and experienced significant body weight reductions ranging from 6% to 11% in just six weeks. The result exceeded that obtained with liraglutide, an approved drug used as a reference comparator in the study. Somewhat surprisingly, both drugs' side effect profiles were similar.
A second important trial tested what happens when Cagrilintide is combined with Semaglutide. The combination had even more dramatic effects. The weight loss was not the sum of each drug's effect ? it was greater. Scientists think this is because the two drugs have a synergistic effect, i.e., they enhance each other's effect. In this study, patients lost up to 17.1% body weight over 20 weeks. To put this into perspective, a 200-pound individual could lose about 34 pounds in five months.
Cagrilintide and Diabetes:
Cagrilintide, along with similar drugs like pramlintide, has also shown great promise in treating type 2 diabetes. These drugs render type 2 diabetes more manageable by lowering insulin resistance and A1C levels through the inhibition of the release of glucagon, a hormone that elevates blood sugar levels.
Studies have shown that the injection of these peptides can lead to the reduction of A1C ? by about 2.2% over a relatively short period of time.
Among the numerous features that set Cagrilintide apart is its convenience. It is dosed only once a week, which makes it easier for patients to stay on therapy. The once-weekly dosing and its extended duration of action allow for more stable blood glucose levels over time, and for individuals using it for weight loss, that extended half-life also continuously suppresses appetite.
Cagrilintide and Alzheimer's Disease:
There has been a growing understanding of how blood sugar levels affect the health of the brain, especially as it relates to memory and cognitive function. Diabetes, for example, is often accompanied by problems like reduced cognition, shorter attention span, and memory loss ? even in young people. When the blood glucose level is high (a condition known as hyperglycemia), it can induce harmful changes in the brain, such as inflammation, oxidative stress, and damage to brain cells.
This not only impacts mental sharpness but also may contribute to other complications common in diabetes, such as heart and kidney disease.
Science has always shown a strong connection between cognitive function and blood glucose levels. Too high glucose levels can be harmful, but most studies address the effects of too much sugar in the bloodstream. In one such study, a group of older women was monitored for four years, and it was found that consistently high blood sugar was linked to a higher risk of both mild memory issues and more serious maladies like dementia.
One of the surprising findings is that high blood sugar can ultimately decrease glucose availability in the brain. Since the brain uses almost nothing but glucose as fuel, this has the potential to be a big deal. Another study adds to this one by showing that as the brain becomes resistant to insulin, it can't properly use glucose, something scientists believe contributes, first and foremost, to the cognitive impairment seen in people with diabetes.
Put briefly, these studies show that the brain's failure to metabolize glucose ? especially when blood sugar levels are consistently high ? can be a significant contributor to the development of dementia and other forms of cognitive impairment.
Conclusion:
While mostly combined with Semaglutide, Cagrilintide still offers plenty of benefits. It stimulates weight loss, helps with diabetes, and influences Alzheimer's disease. Unfortunately, these findings are still in the experimental stage, and more research is required to ensure this peptide is completely safe for human use.
You can discuss the treatment plan with your doctor if you start with Cagrilintide. They will propose the best course of action and ensure your health and safety aren't jeopardized during this treatment.
QUANTITY
Dosing
Cagrilintide Dosage Chart (Weekly Injection)
| Treatment Phase | Dosage (mcg) | Duration | Notes |
| Week 1?2 (Initiation) | 0.3 mg (300 mcg) | 2 weeks | Start with a low dose to assess tolerance and minimize side effects. |
| Week 3?4 | 0.6 mg (600 mcg) | 2 weeks | Gradual increase to improve appetite control and minimize nausea. |
| Week 5?6 | 1.2 mg (1200 mcg) | 2 weeks | Continue titration to increase weight loss effect. |
| Week 7?8 | 1.8 mg (1800 mcg) | 2 weeks | Monitor for side effects; adjust if needed. |
| Week 9 and onward | 2.4 mg (2400 mcg) | Maintenance dose | Target maintenance dose for long-term weight loss and glucose control. |